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ETHICS CENTER 
250 ATTEND FIRST 
NATIONAL ETHICS 
CONFERENCE 
Over 250 people attended the 
regular sessions of "Biomedical 
Ethics Today: Old Models and New," 
~ conference sponsored by Loma 
....inda University's Ethics Center and 
the Hastings Center of New York on 
April 21 and 22 with financial 
assistance from the California Coun-
cil for the Humanities. The audience 
for the Sunday evening discussion of 
ethical issues in organ transplantation 
swelled to approximately 1,500 per-
sons. About ten percent of those who 
registered for the entire conference 
came from states other than Califor-
nia, some coming from places as far 
away as Rochester, New York and 
New Orleans, Louisiana. The majority 
of those who participated in the entire 
conference were physicians or 
nurses, but a number of dentists, 
lawyers, ministers, chaplains, welfare 
workers, and psychologists were also 
present. 
The conference received favorable 
and frequent coverage from the news 
media that included extensive 
coverage of the Sunday even~hg 
discussion by one of the national 
television networks. A number of 
peaceful but vocal protestors of the 
alleged misuse of animals and 
humans in some medical experiments 
.1dded to the session's aura of 
anticipation. 
This first national ethics conference 
at Loma Linda focused on several 
contemporary issues including ethical 
problems in neonatology, death and 
dying , organ transplantation , 
allocating health care in the United 
States and in the third world , and the 
uses of living beings in therapy and 
research. Each of the sessions began 
with a major presentation from 
someone from either the Hastings 
Center or LLU's Ethics Center. A clini-
cian and a scholar from one of the 
humanities then commented on the 
topic from his or her perspective. This 
was followed by questions and com-
ments from the audience. 
The formal evaluations submitted 
by those who attended the con-
ference indicated that they were 
pleased with the quality of the presen-
tations, the organization of the 
conference, and the facilities. The 
evaluations also encouraged the 
Ethics Center to provide more oppor-
tunities at subsequent conferences 
for attendees to become acquainted 
with each other and with their various 
viewpoints and to tailor the presenta-
tions even more closely to the prac-
tical needs of clinicians. 
The staff of the Ethics Center is 
planning to publish the conference's 
major presentations in some way in 
the near future, though these plans 
have not yet been fully finalized . 
Extensive excerpts from the Sunday 
evening discussion of ethical issues 
in" organ transplantation are available 




liTHE HIGH COST 
OF DYING" 
Alexander M. Capron, Topping Pro-
fessor of Law, Medicine, and Public 
Policy at the University of Southern 
California, will deliver a lecture on 
" The High Cost of Dying" at Loma 
Linda University Medical Center on 
October 9. 
The Capron lecture will begin at 
noon in the Medical Center's A-level 
amphitheater when the monthly 
Medicine and Society Conferences 
resume following the summer vaca-
tion. Charles Teel , Jr., Chairman of 
LLU's Department of Christian Ethics 
and a specialist in questions of social 
justice, will respond to Professor 
Capron's presentation. The last 15 
minutes of the hour-long program will 
be reserved for audience discussion 
to be moderated by James Walters. 
Attendance is open to all without ad-
mission charge. Funding for the 
monthly meetings is provided by The 
Wuchenich Foundation. 
Before assuming his duties at the 
University of Southern California, 
Capron served for three years as the 
Executive Director of the President's 
Commission for Ethical Problems in 
Medicine and Biomedical and 
Behavioral Research. Before that he 
taught at Georgetown University, the 
University of Pennsylvania, Yale 
University, and the University of 
Connecticut. He has also served on 
the Board of Directors of the Hastings 
Center in New York and the American 
Society of Law and Medicine in 
Boston. In addition to the works 
published by the President's Commis-
sion , he is the author of two books, 
three major discussions in the 
Encyclopedia of Bioethics, and 
nearly 100 other scholarly articles. 
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Letters to the Editor 
Dear Editors: 
I read the first issue from cover to cover. 
While I enjoyed it, I felt it was a bit sub-
jective on the side of cross species 
transplants and the more utilitarian view 
of controversial medical practices. 
While I support fully continued research, 
I think we need better answers to the 
ethical questions that are being raised. 
As you know probably better than I, this 
whole question of medical ethics came 
into sharp focus at the Nuremberg war 
crimes trial in 1945-46. Growing out of 
that series of trials was the Nuremberg 
Code. The central provision of the Code 
holds that "the voluntary consent of the 
human subject is absolutely essential 
... the duty and responsibility for ascer-
taining the quality of the consent rests 
upon each individual who initiates ... 
the experiment." 
With adults that is not an ethical 
dilemma unless the adult is not capable, 
for whatever reasons, of understanding 
the issues and making an intelligent 
decision. However, for a baby that code 
provides little help. Consequently there 
is a pressing need to develop a more 
comprehensive ethic to guide u_s in 
these matters. 
Also, while the larger good of society 
demands experimentation in the area of 
medical science, if some clear code of 
ethics is not developed, the issues will 
be left to the whim of the rich, the am-
bitious, and the opportunist. 
John W. Fowler 
Ohio 
An Editorial 
OUR TWOFOLD POTENTIAL 
I developed a commitment to "pre-
sent truth" from my earty retigious 
education. Formulations of truth will 
change, t was taught, as circum-
stances alter and as culture shifts. 
However, individuals, churches and 
societies are tempted to repeat old in-
sights irrespective of new contexts. In 
the name of present truth, such com-
placence must be labeted debifitating-
spiritually, yes, but also humanly. 
Reexamination is constant, says 
historic Adventism. According to an 
ancient sage, "The life which is 
unexamined is not worth living." 
Society is now giving unprec-
edented reexamination to the health-
care industry. Adventism has three 
compelling reasons for participating 
in this reexamination: (1) a heavy 
financial investment in health care, (2) 
a doctrinal commitment to holistic 
religion, and (3) a rich history of 
distinctively Adventist hospitals. 
Battle Creek Sanitarium in Michigan 
was founded in 1866-three years 
after the organizaHon of the Seventh-
day Adventist denomination. Today 
the church has over four million 
members and it operates a world-wide 
chain of 200 hospitals that create an 
annual revenue of some two billion 
dollars. 
Many of the issues facing medicine 
and health-care today are conceptual, 
ethical, and ultimately religious. The 
formation of the humanistically-
oriented Hastings Center, a bioethics 
think-tank near New York City J is 
noteworthy. The Roman Catholic 
tradition, rich in moral deliberation, 
fosters the Kennedy Institute of Ethics 
in Washington, D.C. LLU's Center for 
Christian Bioethics is a fledging; our 
chaUenges are great and our oppor-
tunities are many. 
The Loma Linda University Ethics 
Center's potential is twofold: 
First, to faciUtate Adventist think-
ing. InSightful commentary on the 
integral relationship of religion and 
health exists in Etlen White~s writings, 
but new circumstances compel refor~ 
mulation. In the 19th century, Adven-
tists developed the sanitarium model 
of health-care. Today this model has 
largely yielded to the acute hospital 
concept. What distinctive mission-
if any-should today's Adventist 
hospitals be serving? American 
health care is today, just as it was 100 
years ago, undergoing radical revi-
sion. What is Adventism's vision? Are 
the church's traditional emphases on 
bodily health, human freedom and 
preventive medicine only personal 
counsel, or is there relevance to 
modern medical dilemmas: the right~ 
to-die, abortion, and health-care 
delivery? The relationship of church 
teachings to clinical issues is not self-
evident and application of these 
principles will require in*depth 
collaboration among church leaders, 
hospital administrators and 
theologians. The Ethics Center could 
serve as a catalyst to an exciting and 
uncharted Adventist future in health 
care. 
Second, to enrich societal 
discussion. Most bioethics institutes 
unwittingly, and appropriately, 
presuppose the humane values of 
Western civilization-values derived 
largely from the Judeo-Christian tradi-
tion. LLU's Ethics Center is in funda-
mental agreement with these values 
and it is in a unique pOSition to ponder 
them and to enhance them in light of 
the church's commitment to their 
wellspring: Judeo-Christianity. 
American bioethics is only as fertile 
as the insights emerging from a 
variety of thoughtful communites. 
Given the Adventist commitment to 
Biblical theology, Christian holism 
and human freedom, the Ethics 
Center can enrich the quality of 
society's bioethical discussion. 
Innovating in the 20th century will 
take no less energy, stamina, and 
courage than did pioneering in the 
19th. Are we-churCh, supporter, and 
ethidsts-up to the challenge? The 
answer is now being formulated by 
our corporate response. 
James Walters 
( REFLECTIONS REGARDING ORGAN TRANSPLANTATION . 
On Sunday evening, April 2 1, the Hastings Center's Arthur Caplan presented a public lec-
ture on "Ethical Challenges of Organ Transplantation: Allografts, Xenografts, and Artificial 
Organs." The panel that responded to Doctor Caplan included Doctors Leonard Bailey, 
M. C. Theodore Mackett, Jack W. Provonsha, Richard Sheldon, Bruce Wilcox, and Charles 
Teel, Jr. of Loma Linda University, and Dan D. Rhoades of the School of Theology at Clare-
mont. Alexander M. Capron, formerly of the President's Commission on Bioethics and now 
at the University of Southern California, was the moderator. The following edited excerpts 
indicate the friendly and frank tone of the evening's conversation. Audio cassettes of the 
entire session are available for a modest charge from Study Tapes, 1341 Pine Knoll, 
Redlands, California 92373. Video cassettes are available from the Loma Linda University 
Church, Loma Linda, California 92350. 
Caplan: Tonight I want to say some things in general 
about organ transplantation, and then I'll comment on 
xenografts and the Baby Fae case. I'm putting the two 
topics together because I think they are closely related. 
What progress has occurred in the organ transplant 
field? Last year in the United States there were something 
on the order of 6,000 kidneys transplanted. Last year 172 
heart transplants were performed. Somewhere between 
250 and 300 liver transplants were performed, and a 
variety of other tissue~ were transplanted. 
The number of people awaiting kidney transplants may 
be as high as 22,000 or 25,000, since about 71 ,000 people 
are on dialysis machines. If the physical restrictions on 
heart transplants were relaxed, if people felt more confi-
dent about heart transplants in older and younger people 
or in patients with other complicating conditions, that 
number could grow to as high as 10,000. The harsh fact 
is that a big gap exists between supply and demand. 
Who should pay for these procedures? It would cost 
about $200,000 to do a liver transplant at Pittsburg on a 
young child. A heart transplant at Stanford probably costs 
between $80,000 and $120,000, and a pancreas 
transplant $40,000 or $50,000 per procedure. 
Who will decide who will get the scarce liver or kidney 
tissue? Some people say, "In America we have a system 
that doesn't ration." But in the transplant field that is not 
true. We have a rationing system in place which operates 
according to what I will refer to as a green screen. We 
use the ability-to-pay to decide who'll get access to certain 
forms of transplantation. At the University of Pittsburg, if 
you do not have in advance the $100,000 or $150,000 for 
a heart or liver transplant, you will not be put on the waiting 
list. 
I would argue that if a transplant is known to be 
efficacious, if a patient wants l it , and if by giving that 
transplant we don't distort services a community should 
provide to other people, we have an obligation to try to 
make sure that money is not a barrier to access. 
I'm not going to recap the history of Baby Fae here at 
fh. Lorna Linda. But it seems to me that five questions arose 
3d in this case: (1) Did the researchers have a reasonable 
scientific basis for undertaking the experiment when they 
did? (2) Was the informed consent process adequate? (3) 
Is the existing system for regulating human experimen-
tation regarding this kind of a xenograft adequate? (4) Was 
the institution correct in deciding to sequester the informed 
consent form and research protocol? And lastly, (5) Is it 
morally acceptable to use an animal in order to try to save 
human beings? 
I'm going to get rid of the last question right away. My 
answer to that one is basically, "Yes, it is, if we know that 
we can benefit a human being by sacrificing an animal. " 
Was the scientific basis adequate? It was difficult to 
know, but there seemed to be very little independent 
assessment of the scientific basis for the experiment. 
Specialists from Montefiore and Stanford came in and 
looked at some of the immunological information. But 
those people quickly became involved as co-researchers 
in the project. Without independent assessment, without 
the ability of peers to comment critically, I think the scien-
tific basis for the experiment was suspect. 
What about informed consent? The National Institutes 
of Health sent a team out here in December and its report 
"I think the lesson that came out of the 
Baby Fae case is the need to be forthright, 
open, and honest; to disclose informa-
tion." Arthur Cap/an 
was available in March. I found it a very persuasive report 
in answering concerns about informed consent. It 
indicated that the parents seemed fully informed, that Dr. 
Bailey and his colleagues had spent many hours 
discussing the experiment with them, that full complete 
consent had been obtained. But I do criticize the informed 
consent process on the question of whether sufficient 
attention was given to the alternatives-either pursuing 
a human heart transplant from a cadaver source or 
surgical repair of the heart as a temporizing option. All 
options must be presented fully, zealously and fairly. It's 
not enough to say, "There are other alternatives, but we 
don't think they're going to work; we'd like you to think 
of the xenograft." 
This leads me to my major complaint: the question 
about sequestering information. The issue of keeping 
documents secret troubles me deeply. It's the thing that 
bothered me most about the experiment when I 
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commented about it from afar, and it stills bothers me 
today. 
Loma Linda decided not to release the informed con-
sent form at the time of the experiment, and not to release 
the research protocol which, to my knowledge, has not 
been made public to this day. That appears to have been 
a tactical mistake and a terrible blunder. I know from 
talking with Dick Sheldon and reading some of his com-
ments that he believed that the best way to protect the 
researchers was to keep things secret. But I do not agree. 
I believe that when you're operating in an area where 
you're making an innovative, pathfinding breakthrough, 
the public must understand exactly the protections 
afforded the subjects in the experiment, and the scien-
tific rationale. You cannot do that unless you give access 
to those critical documents. Moreover, you cannot do that 
unless you are clear and forthright in fully disclosing the 
review process. Only later, in conversations with Dr. Pro-
vonsha and others at Loma Linda, did I myself learn how 
carefully this particular experiment was reviewed. That 
kind of information should not be kept secret. The public 
must be assured that not only is scientific progress being 
attempted; not only is a good-faith effort being made to 
help a dying child; not only is every effort being made to 
afford the parents of that child a full presentation of their 
options; but also that the experiment is being conducted 
according to the highest standards of human 
experimentation. 
I think it is inevitable that we will have to turn to animal 
sources of tissue and organs for certain types of medical 
problems. I think we ought to do more in procuring human-
cadaver organs and paying for them when we believe they 
can really help people. Most importantly, I think the lesson 
that came out of the Baby Fae case is the need to be forth-
right, open, and honest, to disclose information. I think 
many of Loma Linda's problems concerned the institu-
tion's decision to remain private when I think it would have 
been better and morally obligatory to have gone public. 
Capron: I'm sorry Southern California didn't greet Dr. 
Caplan with sunshine. It's obvious his views are based 
on the notion that sunshine has a good effect on ethics. 
"We weren't totally secretive about Baby 
Fae, but things we let out got distorted to 
the point of falsification . I don't know what 
to do about that." Bruce Wilcox 
I hope that before he leaves we can give him some 
sunshine. 
I'd like to begin with Dr. Leonard Bailey. 
Bailey: Thank you very much, Dr. Capron. Dr. Caplan, 
you're not as bad as I thought you were, and we're not 
as bad as you think we are. ~ I appreciate your erudite 
discussion tonight, and maybe we'll get to some of the 
answers. 
Our project is predicated on a number of things. One 
factor is that uniformly lethal nature of the disease we're 
trying to address. Another is an absence of long-term data 
on the efficacy of palliation in this group. While I support 
what my associates in the East are doing in terms of pallia-
tion, that experience hasn't been duplicated well anywhere 
in the world, and still no long-term data are available. To 
suggest that palliation is somehow better than transplan-
tation is fallacious. Also, there is a virtual absence of 
newborn heart donors-those of us in pediatrics under-
stand the difficulties of making a diagnosis of brain death 
in this age group. When a baby gets to 8 or 10 months 
and has a large cardiomyopathy heart, you can extend 
the donor base to 2 and 3 year olds for even a small in-
fant; but a newborn like Baby Fae has only so much space. 
Wilcox: The issue of secrecy ranks high in what Art has 
had to say. The one thing that strikes me is the difficulty 
of getting correct information to the public. We weren't 
totally secretive about Baby Fae, but things we let out got 
distorted to the point of falsification. I don't know what to 
do about that. If an informed public can make decisions-
and I hope they can-great. But how do we get the cor-
rect information to them? 
Mackett: We've come full circle since the early sixties, 
when baboons were of great interest to several well-known 
surgeons. Recently in Britain I talked with Peter Morris, 
a transplant surgeon of some reknown. When I mentioned 
that we were contemplating a baboon heart transplant in 
the neonate, his face brightened. "By George, it'll work!" 
he said. In his own experience with immunosuppressants 
in the early sixties, an adult patient had survived 9 months 
on a functioning baboon kidney. He had never thought 
of doing something in the neonate. 
Sheldon: On several occa~ions during the years I have 
been IRB Chairman at Loma Linda, I have had the 
opportunity to listen to Art lecture. On one occasion I 
walked out because his lecture so infuriated me. But 
tonight, once again, Art, I congratulate you approaching 
us with some kindness and some understanding. 
I'd like to comment on the secrecy issue. At no time did 
we feel we were maintaining our documents in secret. 
These papers were to be released, as Bruce suggested, 
in a controlled manner through a trustworthy source. I 
have become somewhat critical not only of the Hastings 
Center, but also of PRIMR, Public Responsibility in 
Medicine and Research, because of their "ambulance 
chasing." We did not figure that these documents were 
secret; only that we would release them in a controlled 
manner to an organization that would handle them 
appropriately. 
Capron: Well, besides not giving Dr. Caplan any sun-
shine, we've now decided he's an ambulance chaser-a 
poorly paid one! 
Provonsha: I was Chairman of the Ethics Committee that 
reviewed Dr. Bailey's work. We felt satisfied that there was 
reason to think Baby Fae would be better off with the 
surgery than without it. My chief concern as an ethicist, 
however, has been conditioned by my reaction to the com-
munity of ethicists. It's true that ethicists at a distance did 
not have access to the information we had close at hand. 
It is also true that a fair number of them spoke as if they 
knew what they were talking about before they had the 
facts in hand. It seems to me there's an ethical question 
here. Ethicists have a right to ask questions, but until they 
have the facts they are ethically bound to limit themselves 
to asking questions rather than making positive 
statements. 
Rhoades: It would ill behoove me to raise an issue about 
the use of animal tissue with the Seventh-day Adventist 
community when I eat animals and you do not. Obvious-
ly, I do not have a problem at that point. But on the ques-
tion of secrecy, precisely for the reason Dr. Provonsha 
( 
raised, that others need to ask questions and have infor-
mation, I would disagree with Richard Sheldon. I under-
stand his position, but it seems to me that a primary con-
cern of public policy should be to require all institutions 
to be forthcoming with such information so that responsi-
ble parties throughout the country can be looking over 
each other's shoulders to some extent. I know this is done 
in the long run, but it might have been helpful if a more 
"open" policy had been adopted to begin with. 
"If society is willing to spend enormous 
sums defending this country, it seems 
reasonable to spend some money on 
transplantation. " Leonard Bailey 
Bailey: There truly is a shortage of human organs, and 
it probably is an issue of morality as to how recipients get 
their grafts. I've been appalled at the television hype sur-
rounding some liver grafts. 
I'd like to comment on whether or not it's worthwhile 
to do transplants, and on the idea of keeping some cen-
tralized data collection bank on these. First, I think 
transplants probably are worthwhile to society, whatever 
the costs. They provide some measure of hope that peo-
ple wouldn't otherwise have. If society is willing to spend 
enormous sums defending this country, it seems 
reasonable to spend some money on transplantation. 
The only issue I would take with the centralized data 
collection bank is that I wouldn't single out transplanta-
tion. In all areas of surgery and medicine the same thing 
can be said. 
Wilcox: I can second the need for centralized data col-
lection, but I think I'd better pass on the rest of the sub-
ject until I get my donor card. 
Capron: I have one right here for you . Mine came with 
my new California driver's license, but I already had one 
so I didn't need it. 
"I would second the idea of a required 
request, requiring those who deal with the 
situation-and its not pleasant 
oftentimes-to approach the family on the 
subject of organ harvest." Theodore Mackett 
Mackett: Art, I'm interested in what I've seen as an evolu-
tion in your own ideas in regard to required requests. I 
remember a disclosure you gave on presumed consent, 
that practice followed at least in theory in many of the 
European countries where, if you're rendered brain dead, 
your organs are recovered without regard to the wishes 
of the deceased or the family. 
I would second the idea of a required request, requir-
ing those who deal with the situation-and it's not plea-
sant oftentimes-to approach the family on the subject 
of organ harvest. 
Sheldon: One of my terrors is the pressure that will be 
placed on IRB's at the local level. I've just paid my income 
taxes and I hope I don't get as much government as I paid 
for. The government is no paragon of ethics. I see ahead 
of us an enormous amount of hard work with very little 
to indicate which direction we should go and how we 
should do it, whether we're on the governmental level or 
the local level. It doesn't make a bit of difference. 
Provonsha: One of the most difficult ethical questions we 
face is learning how to see that everybody gets his fair 
share of what he deserves, of what he needs. When you 
start questioning a "green screen" method you also ques-
tion the free enterprise system itself. I'd like to live in a 
classless society with everybody having an equivalent 
amount of money and food and housing and airplanes and 
all the other things we'd like to spread around. I don't know 
how to get such a society without sacrificing other things 
more valuable to me-that is, freedom, which is very high 
on my list of values. I have the suspicion that I may just 
have to wait until I get to heaven before we have a 
classless society without dictatorial restrictions and laws 
that take away some basic freedoms. How to balance 
freedom with the need to allocate fairly is something we 
must address. I don't have good answers for that yet. 
Capron: I think Dr. Provonsha has raised an important 
concern that goes beyond transplantation. But the ques-
tion has to be asked whether health care is different from 
airplanes and televisions and maybe even housing and 
food. We now speed about 11 percent of our gross na-
tional product on health care, but this means we have less 
to spend on other things. The question Dr. Caplan raises 
is, Do we find the use of dollars an acceptable rationing 
mechanism? 
Rhoades: I find myself in strong disagreement with Dr. 
"I've just paid my income taxes and I hope 
I don't get as much government as I paid 
for. The government is no paragon of 
ethics. " Richard Sheldon 
Caplan on part of his statement because it seems to me 
he approached the issue as an economist concerned with 
supply and demand, indicating that money shouldn't pre-
vent more and more people having access to these 
transplants. This seems to be an artificial approach. The 
comments Alexander Capron just made point in a different 
direction. Possibly what we need is a careful assessment 
of the essential medical needs of our people and the 
dollars available, then allocate those resources to best 
utilize the dollars. This probably will require, whether we 
like it or not, public decisions and not just private, free 
decisions by individuals. It seems suspect to suggest that 
it's simply a supply-and-demand matter and that 
everybody ought to be able to have access-the more the 
better-when we aren't even beginning to meet basic 
medical needs. 
Teel: I want to echo Dr. Provonsha that I don't know how 
to achieve a classless society. But I'm not certain I want 
to wait until heaven dawns before wrestling with the ques-
tion, To what extent is health care a right? 
I'm happy I was born in the mid-20th century rather than 
the mid-17th or 18th, at which time American society 
asked "Who deserves to be educated?" and answered, 
"Wealthy, white males." At some point the community 5 
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said, We need better answers than the ones we have. I 
guess I'm appealing that this side of the Apocalypse I think 
it's legitimate to ask, Is health care, no less than educa-
tion, a right? 
Caplan: It's always a pleasure to attempt damage con-
trol while the vessel is sailing forward. 
One issue that has been raised is the responsibility of 
bioethicists or the press where there's an innovative 
medical experiment. Many people at Lorna Linda feel that 
LLU came in for harsh and unfair criticism. That is not my 
impression. Many of the criticisms were raised in a con-
ditionalized fashion! "If this is true, then that would be 
bad." That is not to say that no one in the bioethics com-
munity pronounced things that subsequently turned out 
to be factually false. Nor is it the case that everyone in 
the press adequately reported what took place. 
But I don't think for a minute it is wrong to pay close 
attention to an innovative medical experiment when a child 
is involved. I also believe it's important to ask, "Is the 
scientific basis, there?" and "How well was the informed 
consent handled?" 
Let me, if I may, Alex, say a word about the issue of 
heaven and the classless society. I did say that it was not 
simply a matter of supply and demand because I gave you 
three criteria for committing resources: First, Does it work 
the way people who do it claim it works? Second, Do peo-
ple want it? And third, I told you I didn't want it done or 
paid for, or resources allocated, if it distorted what was 
available to others. So I reject the idea that I'm simply giv-
ing a supply-and-demand analysis. 
Let me come, finally, to the issue of cadavers. I still 
believe presumed consent is ethically acceptable. That 
is, if you could assure people the right to object, to opt 
out of a system in which people were presumed to be 
donors unless they or their family had an objection, that 
would be to me an ethically acceptable way to procure 
tissue. What made me change my mind about presumed 
consent was not the ethics but the practice. If someone 
can think of a way to do it practically, I have no objection 
to it. 
Capron: One issue is sort of the flip side of what Dr. 
Caplan has mentioned. It would have been a lot easier 
for people in the position of Art Caplan who are called on 
to comment on something ethically, and it would also 
would have been easier for scientists called on by the 
press to give their views, if this case had come up in the 
normal processes of notice to the scientific community 
rather than being called on and having to say to the 
reporter, "You'll have to give me the details; I haven't read 
anything about it yet." 
So that Arthur's kindness can be better understood, I'd 
like to read something and then give Dr. Bailey the clos-
ing minutes to respond to it. There was at least one critic 
who fully met Dr. Bailey's description-Professor George 
Annas of Boston University. In the Hastings Center Report 
he summed up his views by saying, "This inadequately-
reviewed, inappropriately-consented-to, premature experi-
ment on an impoverished terminally-ill newborn was un-
justified." Because Arther has said such nice things this 
evening, I want to give you an opportunity to confront one 
of your more strident critics with anything you'd like to say. 
Bailey: It does make you wonder to whom ethicists are 
accountable. Several months before Baby Fae, Magdi 
Yacoub, active in London, did a similar transplant in a 
baby. Where were all the ethicists when that was done? 
The only difference is that we used a cross-species 
transplant. He got a few bylines and that was the end. 
Because we crossed the species line we got all the publici-
ty and the ethicists came out to greet us. I'd like to throw 
that back to Dr. Caplan. Where were you when Magdi 
Yacoub did the first newborn heart transplant, and why 
was ours wrong and his was right, when it was an abject 
failure scientifically? And without any experimental 
background, I might add. 
Caplan: That does give me an opportunity to say 
something really saccharin. Nonetheless, I'm going to say 
it at the risk of leaving me with diabetes. It is this: we have 
a better system of human experimentation protection than 
the British do. What goes on in England, you would not 
want to take place here. I think the British human ex-
perimentation system is much more dependent on the 
discretion of the researcher. I think the regulations and 
committee review they operate under do not accord dignity 
and autonomy to subjects. I have problems with the British 
system and Dick Sheldon and I have argued about it over 
the years. I still think there should be tough review par-
ticularly where children are concerned. I'd rather have this 
system than their system. The reason you don't hear me 
bemoaning a transplant in England is that I think they're 
back in the 1950s with respect to medical ethics in the 
human experimentation area. 
"It does make you wonder to whom 
ethicists are accountable." Leonard Bailey 
Bailey: You may, of course, live to regret those 
statements. 
Caplan: Where are the British? 
Bailey: The British are coming! 
Caplan: Well, I'm going there in July. We'll see. 
Capron: You may not be able to get a visa! 
Caplan: That's right! 
Bailey: The one concept that I think has eluded our 
speaker tonight, and George Annas even more so, is the 
fact that the Baby Fae project is a rather natural exten-
sion of what I do every day. It is not very different from 
innovative things that are done each day in my operating 
room without IRB approval, or with IRB approval, simply 
by the nature of the diseases I deal with. 
Capron: This has been extraordinarily interesting even-
ing for me. Senator Albert Gore of Tennessee has said, 
"There are many lessons learned in the extraordinary at-
tempt to save the life of Baby Fae, but one lesson stands 
above all the rest: the need for a new partnership between 
society and the medical profession to create a sustained 
dialogue about the increasingly difficult bioethical issues 
confronting us." 
The creation of the Ethics Center here at Lorna Linda 
which this symposium celebrates is one step. The ex-
istence of other centers, such as the Hastings Center in 
New York, is another step. I hope you all will continue to 
give your interest and support so that those who are on 
this panel who are physicians, like those of us who are 
concerned citizens, will have means for discussing these 
important issues. 
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Audio cassettes of the presen-
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the discussions of "What's A 
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Transplantation: Human, 
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University Church, Loma 
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Riverside, CA 92515-8247 or 
call (714) 785-2041. 
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Lorna Linda University 
Lorna Linda, California 92350 
DO CANCER PATIENTS 
EXPECT TOO MUCH? 
"My doctor doesn't talk to me." 
"My doctor has abandoned me." 
liMy doctor says I have 
psychological problems when I com-
plain about my disease, and I feel 
hopeless and helpless to do anything 
about it." 
Such are the sentiments of cancer 
patients, according to Stephen R. 
Harrison, a University of Caifornia at 
Los Angeles psychiatric resident who 
has specialized in the physician/ 
cancer-patient relationship. Harrison 
was one of four panelists who led the 
May 8 Medicine and Society Con-
ference, a monthly session held in a 
LLU Medical Center amphitheater. 
Panelist Diana Champ, 31, with 
stage IV ovarian cancer, detailed 
good and bad experiences with physi-
cians. Her present physician, found 
through personal diligence, she says, 
"treats me as a person and not just 
as a disease." 
Oncologist Irvin Kuhn, a professor 
of internal medicine at Loma Linda, 
agreed with the ideal: an oncologist 
who possesses great sensitivity and 
insight plus a high degree of medical 
expertise. However, he questioned 
the .excessively high expectations 
some have for the oncologist! patient 
relationship. "The innate physician 
personality means that doctors are 
more the egghead than the salesman 
type. This is especially true of the in-
ternist; after years of acquiring the 
needed medical knowledge, there is 
little time or energy left also to master 
interpersonal relationships." Panelist 
Kuhn also indicated that patient per-
sonalities range from the "eternally 
optimistic to the infernally depressed." 
It is difficult for the medically-trained 
physician to know precisely how to 
deal with such a variety of mental 
stress. "A meaningful doctor/patient 
relationship," said Kuhn, "is depen-
dent on the coming together of 
various factors: educational level, pa-
tient gender, marital status, family 
support, and financial status." 
Mary Hoban, an oncological nurse 
who lectures at U.C.L.A.'s School of 
Nursing, told the store of a busy and 
personable oncologist: "He always 
walked in and pulled up a chair and 
sat down by the patient. Sometimes 
he didn't sit but 30 seconds. He 
always asked the patient how he was, 
and at some point in the conversation 
touched the patient. Invariably his 
parting words were, 'I'll see you 
tomorrow. ' "These small gestures, 
according to Hoban, "made all the 
difference in the world." 
Brief statements by the panelists 
were followed by audience comments 
and questions. One member of the 
audience regretted the lack of time to 
explore thoroughly the differing 
perspectives, but was pleased that 
"at least the various professionals are 
talking to each other." 
The Medicine and SOCiety Con-
ferences are held on the second 
Wednesday of each month during the 
regular school year at noon in the A-
level amphitheater of the LLU Medical 
Center. The public is invited, and 
there is no fee. The conferences arr 
jointly sponsored by the Ethics Cent~ 
and the LLU School of Medicine. The 
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